Julie Maynard

2.7k total citations · 1 hit paper
24 papers, 1.9k citations indexed

About

Julie Maynard is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Julie Maynard has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 8 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Julie Maynard's work include Genetic factors in colorectal cancer (9 papers), Neurofibromatosis and Schwannoma Cases (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Julie Maynard is often cited by papers focused on Genetic factors in colorectal cancer (9 papers), Neurofibromatosis and Schwannoma Cases (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Julie Maynard collaborates with scholars based in United Kingdom, United States and Singapore. Julie Maynard's co-authors include Julian R. Sampson, Jeremy P. Cheadle, Angela Hodges, Nada Al Tassan, Geraint T. Williams, Nikolas H. Chmiel, Alison L. Livingston, Nicholas I. Fleming, D. Rhodri Davies and Sheila S. David and has published in prestigious journals such as The Lancet, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Julie Maynard

24 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors

2002 980 citations Nada Al Tassan, Nikolas H. Chmiel et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie Maynard United Kingdom	16	1.1k	829	701	460	319	24	1.9k
Anne Forus Norway	24	384 0.4×	873 1.1×	567 0.8×	494 1.1×	118 0.4×	48	1.9k
Maartje Nielsen Netherlands	24	1.4k 1.3×	677 0.8×	816 1.2×	703 1.5×	51 0.2×	79	2.0k
Uwe Kordes Germany	21	585 0.5×	1.1k 1.3×	250 0.4×	322 0.7×	197 0.6×	58	1.6k
Mats Merup Sweden	24	969 0.9×	739 0.9×	632 0.9×	106 0.2×	62 0.2×	59	2.2k
Katrin M. Carlson United States	10	224 0.2×	716 0.9×	497 0.7×	160 0.3×	244 0.8×	13	1.9k
Marianne Tiainen Finland	19	406 0.4×	779 0.9×	483 0.7×	217 0.5×	31 0.1×	26	1.4k
Colm Hennessy United Kingdom	13	274 0.3×	542 0.7×	524 0.7×	232 0.5×	72 0.2×	19	1.1k
Viviana Gismondi Italy	17	692 0.6×	297 0.4×	472 0.7×	253 0.6×	28 0.1×	45	1.0k
Simone Hettmer Germany	23	212 0.2×	714 0.9×	270 0.4×	193 0.4×	123 0.4×	62	1.3k
Rudy M. Landsvater Netherlands	12	220 0.2×	780 0.9×	574 0.8×	290 0.6×	218 0.7×	15	1.9k

Countries citing papers authored by Julie Maynard

Since Specialization

Citations

This map shows the geographic impact of Julie Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Maynard more than expected).

Fields of papers citing papers by Julie Maynard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Maynard. The network helps show where Julie Maynard may publish in the future.

Co-authorship network of co-authors of Julie Maynard

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Maynard. A scholar is included among the top collaborators of Julie Maynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Maynard. Julie Maynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomas, Laura E., Julie Maynard, Peter Giles, et al.. (2019). APC transcription studies and molecular diagnosis of familial adenomatous polyposis. European Journal of Human Genetics. 28(1). 118–121. 3 indexed citations

Madi, Ayman, David J. Fisher, Tim Maughan, et al.. (2018). Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy. European Journal of Cancer. 102. 31–39. 28 indexed citations

Thomas, Laura E., Kevin E. Ashelford, Matthew Mort, et al.. (2017). Burden and Profile of Somatic Mutation in Duodenal Adenomas from Patients with Familial Adenomatous- and MUTYH -associated Polyposis. Clinical Cancer Research. 23(21). 6721–6732. 19 indexed citations

Madi, Ayman, David J. Fisher, Tim Maughan, et al.. (2017). Comprehensive pharmacogenetic profiling of the epidermal growth factor receptor pathway for biomarkers of response to, and toxicity from, cetuximab. Journal of Medical Genetics. 54(8). 567–571. 4 indexed citations

Rashid, Mamunur, Andrej Fischer, Catherine H. Wilson, et al.. (2015). Adenoma development in familial adenomatous polyposis and MUTYH‐associated polyposis: somatic landscape and driver genes. The Journal of Pathology. 238(1). 98–108. 32 indexed citations

Colley, James, Siân Jones, Anthony R. Dallosso, et al.. (2005). Rapid recognition of aberrant dHPLC elution profiles using the Transgenomic NavigatorTM software. Human Mutation. 26(2). 165–165. 4 indexed citations

Tassan, Nada Al, Tim Eisen, Julie Maynard, et al.. (2004). Inherited variants in MYH are unlikely to contribute to the risk of lung carcinoma. Human Genetics. 114(2). 207–210. 34 indexed citations

Maynard, Julie, et al.. (2003). Characterizing mutations in samples with low-level mosaicism by collection and analysis of DHPLC fractionated heteroduplexes. Human Mutation. 21(2). 112–115. 37 indexed citations

Sampson, Julian R., Sunil Dolwani, Siân Jones, et al.. (2003). Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. The Lancet. 362(9377). 39–41. 307 indexed citations

10.

Tassan, Nada Al, Nikolas H. Chmiel, Julie Maynard, et al.. (2002). Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nature Genetics. 30(2). 227–232. 980 indexed citations breakdown →

11.

Parry, Lee, Julie Maynard, Angela Hodges, et al.. (2000). Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours. Human Genetics. 107(4). 350–356. 32 indexed citations

12.

Upadhyaya, Meena, Martino Ruggieri, Julie Maynard, et al.. (1998). Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Human Genetics. 102(5). 591–597. 117 indexed citations

13.

Maynard, Julie & Meena Upadhyaya. (1998). High-Throughput Screening for the Detection of Unknown Mutations: Improved Productivity Using Heteroduplex Analysis. BioTechniques. 25(4). 648–651. 6 indexed citations

14.

Maynard, Julie, Michael Krawczak, & Meena Upadhyaya. (1997). Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene. Human Genetics. 99(5). 674–676. 21 indexed citations

15.

Upadhyaya, Meena, Julie Maynard, Michael J. Osborn, & P S Harper. (1997). Six novel mutations in the neurofibromatosis type 1 (NF1) gene. Human Mutation. 10(3). 248–250. 12 indexed citations

16.

Upadhyaya, Meena, M. Osborn, Julie Maynard, & Peter S. Harper. (1996). Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene. American Journal of Medical Genetics. 67(4). 421–423. 24 indexed citations

17.

Upadhyaya, Meena, et al.. (1996). Mutational and functional analysis of the neurofibromatosis type 1 ( NF1 ) gene. Human Genetics. 99(1). 88–92. 85 indexed citations

18.

Upadhyaya, Meena, Julie Maynard, M. Osborn, et al.. (1995). Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.. Journal of Medical Genetics. 32(9). 706–710. 35 indexed citations

19.

Upadhyaya, Meena, et al.. (1995). Germinal mosaicism in facioscapulohumeral muscular dystrophy (FSHD). Muscle & Nerve. 18(S13). S45–S49. 29 indexed citations

20.

Upadhyaya, Meena, Ming Shen, James M. Farnham, et al.. (1992). Analysis of mutations at the neurofibromatosis 1 (NF1) locus.. Human Molecular Genetics. 1(9). 735–740. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact